November 13, 2016 Bio/Pharma/CRO Life Science Tools Product Launch

QIAGEN Introduces Novel Technology for Customized RNAi Assay Products

VENLO, The Netherlands, November 13 /PRNewswire-FirstCall/ -- - Worldwide First Solution for Flexible siRNA Selection Provides New Dimension of Utility and Performance in one of Life Sciences' Most Promising Disciplines QIAGEN, (Nasdaq: QGEN; Frankfurt, Prime Standard: QIA) the world's leading provider of products for pre-analytical sample preparation and a leader in molecular diagnostics, has introduced... Read more

October 19, 2016 Life Science Tools Product Launch

SeqLL Launches Early Access Program for New true Single Molecule Sequencing (tSMS™) Benchtop System

Quantitative sequencing platform addresses limitations of other sequencing technologies October 19, 2016 06:42 AM Pacific Daylight Time WOBURN, Mass.–(BUSINESS WIRE)–SeqLL, LLC today announced the launch of the tSMS System Early Access Program giving researchers priority access to its proprietary quantitative sequencing platform. This benchtop system has been designed to deliver unparalleled quantitative RNA and specialty... Read more

July 23, 2016 Bio/Pharma/CRO Life Science Tools M&A, Partnerships

QIAGEN Exchange Offer for Digene Corporation Expired With Significant Over 90% of Shares Tendered

VENLO, The Netherlands, July 23 /PRNewswire-FirstCall/ -- QIAGEN N.V. (Nasdaq: QGEN; Frankfurt, Prime Standard: QIA) today announced that its offer to exchange cash and stock for all outstanding shares of Digene Corporation (Nasdaq: DIGE) expired as scheduled at 11:59 p.m., New York City time, on Friday, July 20, 2007. All conditions of the exchange offer... Read more

November 9, 2015 Bio/Pharma/CRO Life Science Tools

It Takes Two: GE Healthcare and SHINE team up to solve longstanding radiopharmaceutical supply concerns in medical imaging

CHALFONT ST. GILES, UK – 9 November 2015 – Technetium-99m (Tc‑99m) is used in more than 40 million medical imaging procedures each year, primarily stress tests to assess heart disease, and bone scans to determine the stage of cancer progression. This essential medical isotope is generated in pharmacies and hospitals from another isotope—molybdenum-99 (Mo-99).  Despite... Read more

October 1, 2015 Life Science Tools

PacBio Sequencing for Human Biomedical Research to be Featured at ASHG Annual Meeting

MENLO PARK, Calif., Oct. 1, 2015 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc., (NASDAQ:PACB) a pioneer and leader in long-read sequencing using Single Molecule, Real-Time (SMRT®) Technology, today announced that its technology will be featured in 36 presentations at next week’s American Society of Human Genetics (ASHG) 2015 annual meeting taking place in Baltimore,... Read more

September 30, 2015 Life Science Tools Product Launch

Pacific Biosciences Launches New Sequencing Platform Based on Its SMRT Technology

Sequel™ System Offers Significantly Higher Throughput, Reducing Project Costs and TimelinesMENLO PARK, Calif., Sept. 30, 2015 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc., (NASDAQ:PACB) a pioneer and leader in long-read sequencing using its Single Molecule, Real-Time (SMRT®) Technology, today announced it has launched a new nucleic acid sequencing platform. The Sequel™ System provides higher... Read more

July 13, 2015 Acad, Gov/Utilities Life Science Tools Microscopy Product Launch

New Publications Highlight Utility of Single Molecule, Real-Time Sequencing for Structural Variation Detection, Haplotype Reconstruction and De Novo Human Genome Assembly

MENLO PARK, Calif., July 13, 2015 (GLOBE NEWSWIRE) — A number of new scientific publications demonstrate the growing momentum for using Single Molecule, Real-Time (SMRT®) Sequencing to capture genetic variants that other technologies miss, according to Pacific Biosciences of California, Inc., (Nasdaq:PACB) provider of the PacBio® RS II Sequencing System. This has been demonstrated through... Read more

May 4, 2015 Life Science Tools

BGI Adopts Single Molecule, Real-Time Sequencing from Pacific Biosciences

MENLO PARK, Calif., May 4, 2015 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc., (Nasdaq:PACB) provider of the PacBio® RS II Sequencing System, today announced that BGI, the world’s largest genomics organization, has purchased its first PacBio RS II instrument and plans to purchase additional units in order to integrate Single Molecule, Real-Time (SMRT®) Sequencing... Read more